Clark D A, Mata I, Kerwin R W, Munro J, Arranz M J
Clinical Neuropharmacology, Division of Psychological Medicine, Institute of Psychiatry, King's College, London, United Kingdom.
Am J Med Genet B Neuropsychiatr Genet. 2007 Apr 5;144B(3):341-3. doi: 10.1002/ajmg.b.30355.
There is evidence to suggest that the alpha(2A)-adrenergic receptor may be involved in schizophrenia. With attention directed at the upstream regulatory region of the gene which codes for this receptor (ADRA2A), we proposed that single nucleotide polymorphisms (SNPs) within this region influences susceptibility to schizophrenia by altering the expression of this receptor. We opted to test for an influence on susceptibility by association study using 112 schizophrenic/schizoaffective disorder patients and 159 controls. The region of interest was screened for SNPs using a combination of bioinformatic searches and sequencing. A total of nine SNPs were discovered, of which four (-5972-G/A, -2211-A/T, -1291-C/G and -261-G/A) were genotyped in the entire clinical sample. No associations were evident, suggesting no influence for these SNPs in susceptibility to schizophrenia.
有证据表明,α(2A)-肾上腺素能受体可能与精神分裂症有关。鉴于注意力集中在编码该受体(ADRA2A)的基因的上游调控区域,我们提出该区域内的单核苷酸多态性(SNP)通过改变该受体的表达来影响精神分裂症的易感性。我们选择通过关联研究来测试其对易感性的影响,使用了112名精神分裂症/分裂情感性障碍患者和159名对照。通过生物信息学搜索和测序相结合的方法对感兴趣区域进行SNP筛查。共发现9个SNP,其中4个(-5972-G/A、-2211-A/T、-1291-C/G和-261-G/A)在整个临床样本中进行了基因分型。未发现明显关联,表明这些SNP对精神分裂症易感性没有影响。